Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05021081 · ClinicalTrials.gov registry record · NA
Visual Performance of Senofilcon A With and Without a New UV/HEV-filter
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 82
- Enrollment target
NCT05021081 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 82 participants.
The verdict
NCT05021081, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
Study Summary
This study will occur in two non-dispensing phases: Phase 1 is a non-randomized, non-masked, non-dispensing study where subjects will wear their own contact lenses for approximately 1 hour. Phase 2 is a controlled, randomized, double-masked, contralateral non-dispensing study where the study lenses will be worn in a daily wear modality for approximately 3 hours.
Interventions
- DEVICE ACUVUE Oasys 1-Day
- DEVICE TRP-200
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2021-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05021081
The ClinicalTrials.gov registry entry for NCT05021081 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACUVUE Oasys 1-Day is the first listed.
NCT05021081 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05021081 about?
NCT05021081 is a clinical study titled "Visual Performance of Senofilcon A With and Without a New UV/HEV-filter". This study will occur in two non-dispensing phases: Phase 1 is a non-randomized, non-masked, non-dispensing study where subjects will wear their own contact lenses for approximately 1 hour. Phase 2 is a controlled, randomized, double-masked, contralateral non-dispensing study where the study lenses ...
What is the current status of trial NCT05021081?
This trial is currently completed. It is a NA study. The enrollment target is 82 participants. The study started on 2021-08-23. Estimated completion is 2021-10-20.
What interventions are being tested in trial NCT05021081?
The interventions under investigation include: ACUVUE Oasys 1-Day (DEVICE), TRP-200 (DEVICE).
Who is sponsoring clinical trial NCT05021081?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.